Work

Relevance of tumor-infiltrating lymphocytes in breast cancer

Year: 2015
Type: review
Abstract: While breast cancer has not been considered a cancer amenable to immunotherapeutic approaches, recent studies have demonstrated evidence of significant immune cell infiltration via tumor-infiltrating lymphocytes in a subset of patient tumors. In this review we present the current evidence highlighting the clinical relevance and utility of tumor-infiltrating lymphocytes in breast cancer. Retrospective and prospective studies have shown that the presence of tumor-infiltrating lymphocytes is a prognostic marker for higher responses to neoadjuvant chemotherapy and better survival, particularly in triple negative and HER2-positive early breast cancer. Further work is required to determine the immune subsets important in this response and to discover ways of encouraging immune infiltrate in tumor-infiltrating lymphocytes-negative patients.
Source: BMC Medicine
Language: English
Subfield: Cancer Research
Open Access status: gold
Estimated APC paid: $4,190
OpenAlex ID: W1963151402
FWCI: 2.489
Cites: 146
Cited by: 257
Related to: 10